Currently, out of the existing stock ratings of Scott Schoenhaus - 46 which are a Buy (92%), 4 which are a Hold (8%)

Scott Schoenhaus

Work Performance Price Targets & Ratings Chart

Analyst Scott Schoenhaus works at KEYBANK and is covering Healthcare, Technology sectors with 95 price targets and ratings displayed on 13 stocks. Previously, Scott Schoenhaus worked at STEPHENS.

Scott Schoenhaus's average stock forecast success ratio is 51.58% with an average time for price targets to be met of 52.38 days.

Most recent stock forecast was given on PGNY, Progyny at 08-Nov-2023.

Wall Street Analyst Scott Schoenhaus

Analyst best performing recommendations are on RXRX.
The best stock recommendation documented was for RXRX at 7/13/2023. The price target of $15 was fulfilled within 6 days with a profit of $2.56 (20.58%) receiving and performance score of 34.3.

Average potential price target upside

of $37.76 (17.98%) on VEEV (VEEVA SYSTEMS).
of $22.35 (10.56%) on TDOC (TELADOC HEALTH).
of $21.25 (10.83%) on IQV (IQVIA HOLDINGS).

TDOC Teladoc Health VCRA Vocera Communications VEEV Veeva Systems IQV IQVIA Holdings OMCL Omnicell ALIT GDRX GoodRx Holdings HQY HealthEquity RCM R1 RCM BNFT Benefitfocus PGNY Progyny PHR Phreesia RXRX

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Lisa Gill (JPMORGAN)